Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Round Table with Drs. Blumenschein and Curran, Bulky Stage IIIB NSCLC
Author
Howard (Jack) West, MD

Here is the third and final case I discussed with two great experts in locally advanced NSCLC. Drs. George Blumenschein, medical oncologist from MD Anderson Cancer Center in Houston, and Wally Curran, radiation oncologist from Winship Cancer Center at Emory University in Atlanta, joined me several weeks ago to discuss a series of challenging cases that illustrate the complexities and array of options in treating patients with stage III NSCLC.

This case is a woman with bulky stage IIIB NSCLC that involves lymph nodes above the collarbone (supraclavicular lymph nodes) on both sides, putting her in the outer reaches of what we could envision being treated for cure. Our discussion includes consideration of the potential approaches, including the potential value of chemo before or after concurrent chemo and radiation. It also covers the difficulty of assessing response after treatment, and the risk of radiation pneumonitis.

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-audio-podcast

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-figures

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-transcript

This program was made possible by a grant from OSI Pharmaceuticals. We are grateful for their support.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora